Austal Ltd (ASB)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 4.160 |
|---|---|
| 52-week range | 3.330 – 8.820 |
| Return, 1 month / 3 months | −7.8% / +10.1% |
| Return, 1 year / 3 years | −39.7% / +139.1% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 65.8% |
| Worst drawdown (1 year) | -61.3% |
| Average daily value traded | 10.44M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Austal Ltd is an Australian shipbuilder that designs and constructs aluminium vessels, chiefly high-speed passenger ferries and naval and patrol craft. It builds commercial ferries for operators on coastal and island routes, and defence vessels such as patrol boats and combat ships for navies, including work for the United States Navy. The company is based in Henderson, Western Australia, and runs shipyards in Australia, the United States and the Philippines, serving both commercial and government customers.
Austal Ltd trades under the code ASB on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Austal Ltd (ASB) trades on the Australian Securities Exchange in Australia. It last closed at AUD 4.160 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 703 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.7% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -52.5% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | -6.1% | ||
| 12-month return, skipping the last month | -34.6% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 65.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -61.3% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 10.44M AUD | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | −7.8% |
| 3 months | +10.1% |
| 6 months | −6.1% |
| 1 year | −39.7% |
| 3 years | +139.1% |
| 5 years | +136.4% |
Signals
| 50-day / 200-day average | 4.253 / 4.659 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.214 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2023 | AUD 0.0300 |
| 15 Mar 2023 | AUD 0.0400 |
| 7 Sep 2022 | AUD 0.0400 |
| 16 Mar 2022 | AUD 0.0400 |
| 8 Sep 2021 | AUD 0.0400 |
| 17 Mar 2021 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.